Predicators of clinical response in patients with high risk acute myeloid leukemia receiving treatment with the histone deacetylase inhibitor sodium valproate

Research output: Contribution to conference (unpublished)Abstract

Authors

  • S Narayanan
  • A Rye
  • Supratik Basu
  • A MacWhannell
  • A Sawers
  • M Cook
  • M Griffiths
  • D Grimwade
  • B Turner

Details

Original languageEnglish
Pages783A
Publication statusPublished - 1 Jan 2005